Home Cart 0 Sign in  
X

[ CAS No. 3435-25-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3435-25-4
Chemical Structure| 3435-25-4
Chemical Structure| 3435-25-4
Structure of 3435-25-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3435-25-4 ]

Related Doc. of [ 3435-25-4 ]

Alternatived Products of [ 3435-25-4 ]

Product Details of [ 3435-25-4 ]

CAS No. :3435-25-4 MDL No. :MFCD02322991
Formula : C5H5ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :MVAXKFAQKTWRAH-UHFFFAOYSA-N
M.W : 128.56 Pubchem ID :581796
Synonyms :

Calculated chemistry of [ 3435-25-4 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 32.01
TPSA : 25.78 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 1.5
Log Po/w (WLOGP) : 1.44
Log Po/w (MLOGP) : 0.54
Log Po/w (SILICOS-IT) : 2.04
Consensus Log Po/w : 1.44

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 0.938 mg/ml ; 0.00729 mol/l
Class : Soluble
Log S (Ali) : -1.65
Solubility : 2.88 mg/ml ; 0.0224 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.62
Solubility : 0.311 mg/ml ; 0.00242 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.29

Safety of [ 3435-25-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3435-25-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3435-25-4 ]
  • Downstream synthetic route of [ 3435-25-4 ]

[ 3435-25-4 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 3435-25-4 ]
  • [ 3438-46-8 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1957, vol. 66, p. 276,289
  • 2
  • [ 3435-25-4 ]
  • [ 3435-28-7 ]
Reference: [1] Chemische Berichte, 1899, vol. 32, p. 2934[2] Chemische Berichte, 1902, vol. 35, p. 1570
[3] Patent: WO2004/96810, 2004, A1, . Location in patent: Page 218
[4] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 5, p. 1261 - 1266
  • 3
  • [ 3435-25-4 ]
  • [ 7664-41-7 ]
  • [ 3435-28-7 ]
Reference: [1] Chemische Berichte, 1899, vol. 32, p. 2934[2] Chemische Berichte, 1902, vol. 35, p. 1570
  • 4
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 5
  • [ 1193-21-1 ]
  • [ 75-16-1 ]
  • [ 3435-25-4 ]
YieldReaction ConditionsOperation in experiment
46% With 1-methyl-pyrrolidin-2-one; iron(III)-acetylacetonate In tetrahydrofuran at 20℃; for 3 h; To a solution of 4,6-dichloropyrimidine (1.0 g, 6.71 mmol) in tetrahydrofuran (30 mL) was added l-methyl-2-pyrrolidinone (3.2 mL, 6.71 mmol), iron(III) acetylacetonate (0.119 g, 0.336 mmol) and methylmagnesium bromide (2.237 mL, 6.71 mmol). The reaction mixture was stirred at RT for 3 h, then it was quenched with water and extracted with ethyl acetate (100 mL). The organic layer was separated out and concentrated under reduced pressure. The residue was purified by silica gel chromatography (20percent ethyl acetate-hexane) to afford 4-chloro-6- methylpyrimidine (0.6 g, 3.08 mmol, 46percent yield) as a colorless gummy liquid. LCMS (ESI) m/e 129.0 [(M+H)+, calcd for C5H6C1N2 129.0]; LC/MS retention time (method D): /R = 1.36 min.
Reference: [1] Patent: WO2017/59085, 2017, A1, . Location in patent: Page/Page column 403; 404
  • 6
  • [ 1193-21-1 ]
  • [ 676-58-4 ]
  • [ 3435-25-4 ]
Reference: [1] Patent: WO2011/63272, 2011, A1, . Location in patent: Page/Page column 46
  • 7
  • [ 3524-87-6 ]
  • [ 3435-25-4 ]
Reference: [1] Patent: US2003/22887, 2003, A1,
[2] Patent: US6509329, 2003, B1,
  • 8
  • [ 3438-55-9 ]
  • [ 98-80-6 ]
  • [ 3435-25-4 ]
  • [ 1353577-56-6 ]
  • [ 1353577-55-5 ]
  • [ 1353577-57-7 ]
Reference: [1] Synthesis, 2011, # 21, p. 3496 - 3506
  • 9
  • [ 56-04-2 ]
  • [ 3435-25-4 ]
Reference: [1] Russian Journal of General Chemistry, 2015, vol. 85, # 1, p. 79 - 87[2] Zhurnal Obshchei Khimii, 2015, vol. 85, # 1, p. 79 - 87,9
  • 10
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 11
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 12
  • [ 3435-25-4 ]
  • [ 51793-97-6 ]
Reference: [1] Chemische Berichte, 1899, vol. 32, p. 2934[2] Chemische Berichte, 1902, vol. 35, p. 1570
  • 13
  • [ 3435-25-4 ]
  • [ 17356-08-0 ]
  • [ 51793-97-6 ]
Reference: [1] Journal of the Chemical Society, 1951, p. 1004,1015[2] Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, vol. 24, p. 84
  • 14
  • [ 3435-25-4 ]
  • [ 5541-07-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1958, vol. 6, p. 633,634[2] Chemical and Pharmaceutical Bulletin, 1959, vol. 7, p. 505,507
[3] Journal of the Chemical Society, 1951, p. 1004,1015[4] Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, vol. 24, p. 84
  • 15
  • [ 3435-25-4 ]
  • [ 141-52-6 ]
  • [ 4718-50-7 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1958, vol. 6, p. 633,634[2] Chemical and Pharmaceutical Bulletin, 1959, vol. 7, p. 505,507
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3435-25-4 ]

Chlorides

Chemical Structure| 4472-45-1

[ 4472-45-1 ]

4-Chloro-2,6-dimethylpyrimidine

Similarity: 0.88

Chemical Structure| 5600-21-5

[ 5600-21-5 ]

4-Chloro-6-methylpyrimidin-2-amine

Similarity: 0.86

Chemical Structure| 67434-65-5

[ 67434-65-5 ]

4-Chloro-5,6-dimethylpyrimidine

Similarity: 0.84

Chemical Structure| 5424-21-5

[ 5424-21-5 ]

2,4-Dichloro-6-methylpyrimidine

Similarity: 0.82

Chemical Structure| 89182-18-3

[ 89182-18-3 ]

4-Chloro-6-methylpyrimidin-5-amine

Similarity: 0.82

Related Parent Nucleus of
[ 3435-25-4 ]

Pyrimidines

Chemical Structure| 4472-45-1

[ 4472-45-1 ]

4-Chloro-2,6-dimethylpyrimidine

Similarity: 0.88

Chemical Structure| 5600-21-5

[ 5600-21-5 ]

4-Chloro-6-methylpyrimidin-2-amine

Similarity: 0.86

Chemical Structure| 67434-65-5

[ 67434-65-5 ]

4-Chloro-5,6-dimethylpyrimidine

Similarity: 0.84

Chemical Structure| 5424-21-5

[ 5424-21-5 ]

2,4-Dichloro-6-methylpyrimidine

Similarity: 0.82

Chemical Structure| 89182-18-3

[ 89182-18-3 ]

4-Chloro-6-methylpyrimidin-5-amine

Similarity: 0.82